WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017191234) PHARMACEUTICAL CARRIERS CONTAINING MIRNAS FOR USE IN THE TREATMENT OF FIBROTIC DISEASES CAUSED BY HYPERGLYCEMIA
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/191234    International Application No.:    PCT/EP2017/060612
Publication Date: 09.11.2017 International Filing Date: 04.05.2017
IPC:
A61K 48/00 (2006.01), A61K 35/28 (2015.01), A61K 35/407 (2015.01)
Applicants: UNICYTE EV AG [CH/CH]; Aawasserstrasse 2 CH-6370 OBERDORF (CH)
Inventors: BRIZZI, Maria Felice; (IT).
CAMUSSI, Giovanni; (IT)
Agent: COMOGLIO, Elena; (IT).
JACOBACCI, Guido; (IT).
QUINTERNO, Giuseppe; (IT).
RAMBELLI, Paolo; (IT).
GERBINO, Angelo; (IT).
FIORAVANTI, Corrado; (IT).
DEAMBROGI, Edgardo; (IT).
RONDANO, Davide; (IT).
VANZINI, Christian; (IT)
Priority Data:
16168546.6 06.05.2016 EP
Title (EN) PHARMACEUTICAL CARRIERS CONTAINING MIRNAS FOR USE IN THE TREATMENT OF FIBROTIC DISEASES CAUSED BY HYPERGLYCEMIA
(FR) SUPPORTS PHARMACEUTIQUES CONTENANT DES MIARN POUR UTILISATION DANS LE TRAITEMENT DES MALADIES FIBROTIQUES PROVOQUÉES PAR L'HYPERGLYCÉMIE
Abstract: front page image
(EN)The invention relates to a new therapeutic application of pharmaceutically acceptable carriers containing miR222. In particular, the invention relates to the use of extracellular vesicles (EVs) which contain the microRNA miR222, in the treatment of fibrotic disease caused by hyperglycaemia, such as diabetic nephropathy and/or renal fibrosis.
(FR)L'invention concerne une nouvelle application thérapeutique de supports de qualité pharmaceutique contenant du miR222. En particulier, l'invention concerne l'utilisation de vésicules extracellulaires qui contiennent le microARN miR222, dans le traitement d'une maladie fibrotique provoquée par l'hyperglycémie, telle que la néphropathie diabétique et/ou la fibrose rénale.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)